European Heart Journal Cardiovascular Pharmacotherapy Impact Factor, Indexing, Ranking



European Heart Journal Cardiovascular Pharmacotherapy Impact Factor, Indexing, Ranking

European Heart Journal Cardiovascular Pharmacotherapy (EHJCP) is a scholarly journal dedicated to publishing research in the field of Medicine. Oxford University Press is the publisher of this esteemed journal. The P-ISSN assigned to European Heart Journal Cardiovascular Pharmacotherapy is 2055-6837 and its abbreviated form is Eur Heart J Cardiovasc Pharmacother.


European Heart Journal Cardiovascular Pharmacotherapy Aim and Scope

The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is an international, English language, peer-reviewed journal with a specific focus on clinical cardiovascular pharmacology. It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews. The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area. While the focus is on clinical topics, basic research articles from fields such as physiology and molecular biology which contribute to an understanding of cardiovascular drug therapy are also considered, such as articles relevant to new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects.


European Heart Journal Cardiovascular Pharmacotherapy Details

Journal title European Heart Journal Cardiovascular Pharmacotherapy (EHJCP)
Abbreviation Eur Heart J Cardiovasc Pharmacother
Print ISSN 2055-6837
Online ISSN 2055-6845
Publisher Name Oxford University Press
Editor-in-chief Professor Stefan Agewall
Subject Category Medicine

European Heart Journal Cardiovascular Pharmacotherapy Abbreviation

European Heart Journal Cardiovascular Pharmacotherapy Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of European Heart Journal Cardiovascular Pharmacotherapy Journal is Eur Heart J Cardiovasc Pharmacother.


European Heart Journal Cardiovascular Pharmacotherapy Ranking

The Ranking of European Heart Journal Cardiovascular Pharmacotherapy in 2024 is 1824. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.


European Heart Journal Cardiovascular Pharmacotherapy Impact Factor

The Impact Factor of European Heart Journal Cardiovascular Pharmacotherapy in 2024 is 7.1. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors


European Heart Journal Cardiovascular Pharmacotherapy SCImago

The SCImago of European Heart Journal Cardiovascular Pharmacotherapy in 2024 is 1.641. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.


European Heart Journal Cardiovascular Pharmacotherapy H-Index

The H-Index of European Heart Journal Cardiovascular Pharmacotherapy in 2024 is 35. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.


European Heart Journal Cardiovascular Pharmacotherapy Quartile

The Quartile of European Heart Journal Cardiovascular Pharmacotherapy is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.


European Heart Journal Cardiovascular Pharmacotherapy Indexing

The European Heart Journal Cardiovascular Pharmacotherapy is indexed in (Indexing details)

PubMed Scopus Web of Science UGC Embase DOAJ

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.


European Heart Journal Cardiovascular Pharmacotherapy Metrics for 2024

Abbreviation Eur Heart J Cardiovasc Pharmacother
Access type Hybrid
Impact Factor 7.1
SJR 1.641
SNIP 1.581
Ranking 1824
CiteScore 8.9
H-Index 35

European Heart Journal Cardiovascular Pharmacotherapy Editorial Board

The Editor-in-chief of European Heart Journal Cardiovascular Pharmacotherapy is Professor Stefan Agewall


European Heart Journal Cardiovascular Pharmacotherapy Submission/Processing Fee (APC)

European Heart Journal Cardiovascular Pharmacotherapy Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of European Heart Journal Cardiovascular Pharmacotherapy is 3828.72 EUR


European Heart Journal Cardiovascular Pharmacotherapy Call for paper

European Heart Journal Cardiovascular Pharmacotherapy Call for paper : European Heart Journal Cardiovascular Pharmacotherapy invites original research contributions for consideration of publication in European Heart Journal Cardiovascular Pharmacotherapy journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.


How to publish in European Heart Journal Cardiovascular Pharmacotherapy

Publishing in European Heart Journal Cardiovascular Pharmacotherapy involves the following steps:

  • Research: Conduct high-quality, impactful research in the field of Medicine.
  • Familiarize Yourself: Read and understand the aims and scope of European Heart Journal Cardiovascular Pharmacotherapy to ensure your work aligns with their focus.
  • Manuscript Preparation: Prepare your manuscript according to the European Heart Journal Cardiovascular Pharmacotherapy guidelines, including formatting, length, and referencing style.
  • Submission: Submit your manuscript through the journal's online submission system.

European Heart Journal Cardiovascular Pharmacotherapy FAQ

is European Heart Journal Cardiovascular Pharmacotherapy journal indexed in PubMed?

Yes, the European Heart Journal Cardiovascular Pharmacotherapy journal is indexed in PubMed.

is European Heart Journal Cardiovascular Pharmacotherapy journal indexed in Scopus?

Yes, the European Heart Journal Cardiovascular Pharmacotherapy journal is indexed in Scopus.

is European Heart Journal Cardiovascular Pharmacotherapy journal indexed in UGC?

Yes, the European Heart Journal Cardiovascular Pharmacotherapy journal is indexed in UGC.

is European Heart Journal Cardiovascular Pharmacotherapy journal indexed in Index Copernicus?

No, the European Heart Journal Cardiovascular Pharmacotherapy journal is not indexed in Index copernicus.

is European Heart Journal Cardiovascular Pharmacotherapy a predatory journal?

No, European Heart Journal Cardiovascular Pharmacotherapy journal is not a predatory journal.

What is the Imptact Factor of European Heart Journal Cardiovascular Pharmacotherapy?

The Impact Factor of the European Heart Journal Cardiovascular Pharmacotherapy is 7.1.

What is the Ranking of European Heart Journal Cardiovascular Pharmacotherapy?

The Ranking of the European Heart Journal Cardiovascular Pharmacotherapy is 1824.

is European Heart Journal Cardiovascular Pharmacotherapy peer reviewed journal?

Yes the European Heart Journal Cardiovascular Pharmacotherapy (EHJCP) journal is a peer-reviewed journal.

is European Heart Journal Cardiovascular Pharmacotherapy a good journal?

Yes the European Heart Journal Cardiovascular Pharmacotherapy journal is a peer-reviewed journal and good to publish your paper.

What is European Heart Journal Cardiovascular Pharmacotherapy?

European Heart Journal Cardiovascular Pharmacotherapy (EHJCP) is a scholarly journal dedicated to publishing research in the field of Medicine. Oxford University Press is the publisher of this esteemed journal.

is European Heart Journal Cardiovascular Pharmacotherapy open access?

Yes, European Heart Journal Cardiovascular Pharmacotherapy is a open access (Hybrid) journal.


Table of Contents

Search For Journals, Indexing, Impact Factor etc.